Protein-Protein Interactions in Drug Discovery, Volume 56 ( Methods and Principles in Medicinal Chemistry )

Publication series :Methods and Principles in Medicinal Chemistry

Author: Alexander Dömling  

Publisher: John Wiley & Sons Inc‎

Publication year: 2013

E-ISBN: 9783527648238

P-ISBN(Hardback):  9783527331079

Subject: R914 pharmaceutical chemistry

Language: ENG

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Description

Treating protein-protein interactions as a novel and highly promising class of drug targets, this volume introduces the underlying strategies step by step, from the biology of PPIs to biophysical and computational methods for their investigation.
The main part of the book describes examples of protein targets for which small molecule modulators have been developed, covering such diverse fields as cancer, autoimmune disorders and infectious diseases. Tailor-made for the practicing medicinal chemist, this ready reference includes a wide selection of case studies taken straight from the development pipeline of major pharmaceutical companies to illustrate the power and potential of this approach.

From the contents:

* Prediction of intra- and inter-species protein-protein interactions facilitating systems biology studies
* Modulators of protein-protein interactions: The importance of Three-Dimensionality
* Interactive technologies for leveraging the known chemistry of anchor residues
* SH3 Domains as Drug Targets
* P53 MDM2 Antagonists: Towards Non Genotoxic Anticancer Treatments
* Inhibition of LFA-1/ICAM interaction for treatment of autoimmune diseases
* The PIF-binding pocket of AGC kinases
* Peptidic inhibitors of protein-protein interactions for cell adhesion receptors
* The REPLACE Strategy for generating Non-ATP competitive Inhibitors of Cell-Cycle Protein Kinases

and more

Chapter

Contents

pp.:  1 – 7

List of Contributors

pp.:  7 – 13

Preface

pp.:  13 – 17

A Personal Foreword

pp.:  17 – 19

3 Modulators of Protein–Protein Interactions: Importance of Three-Dimensionality

pp.:  45 – 79

4 A Leap into the Chemical Space of Protein–Protein Interaction Inhibitors

pp.:  79 – 87

5 Interactive Technologies for Leveraging the Known Chemistry of Anchor Residues to Disrupt Protein Interactions

pp.:  87 – 109

6 SH3 Domains as Drug Targets

pp.:  109 – 125

7 p53/MDM2 Antagonists: Towards Nongenotoxic Anticancer Treatments

pp.:  125 – 153

8 Inhibition of LFA-1/ICAM Interaction for the Treatment of Autoimmune Diseases

pp.:  153 – 189

9 The PIF Pocket of AGC Kinases: A Target Site for Allosteric Modulators and Protein–Protein Interaction Inhibitors

pp.:  189 – 211

10 Retosiban and Epelsiban: Potent and Selective Orally Available Oxytocin Antagonists

pp.:  211 – 249

11 Peptidic Inhibitors of Protein–Protein Interactions for Cell Adhesion Receptors: RGD Peptides and Beyond

pp.:  249 – 281

12 REPLACE Strategy for Generating Non-ATP-Competitive Inhibitors of Cell Cycle Protein Kinases

pp.:  281 – 315

Index

pp.:  315 – 329

LastPages

pp.:  329 – 338

The users who browse this book also browse


No browse record.